Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Option exercise Director acquired 4,660 shares (option exercise)
  2. 4 Option exercise Director acquired 4,660 shares (option exercise)
  3. 4 Option exercise Director acquired 4,660 shares (option exercise)
  4. 4 Option exercise Director acquired 4,660 shares (option exercise)
  5. 4 Option exercise Director acquired 4,660 shares (option exercise)
  6. 4 Option exercise Director acquired 4,660 shares (option exercise)
  7. 4 Option exercise Director acquired 4,660 shares (option exercise)
  8. 4 Option exercise Director acquired 4,660 shares (option exercise)
  9. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,784 shares (to pay taxes)
  10. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 3,224 shares (to pay taxes)
  11. 4 Shares withheld for taxes Interim President and CEO gave up 3,223 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 21,283 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 1,417 shares (to pay taxes)
  14. 4 Open-market buy Director bought 14,500 shares at an average $1.24 ($17,955)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,583 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Business Officer gave up 6,421 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 2,536 shares (to pay taxes)

Page 5 of 21 · 414 filings